Park Avenue Securities’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,947
Closed -$726K 1394
2024
Q1
$726K Buy
10,947
+17
+0.2% +$1.05K 0.01% 808
2023
Q4
$620K Buy
+10,930
New +$573K 0.01% 827
2022
Q4
Sell
-4,080
Closed -$207K 1208
2022
Q3
$207K Buy
+4,080
New +$204K ﹤0.01% 1055

Other funds holding LMAT

Park Avenue Securities's LMAT Position: Q2 2024 in Review

Park Avenue Securities sold out of LeMaitre Vascular (LMAT) in Q2 2024, closing a stake of 10,947 shares — an estimated $726K sold.

Park Avenue Securities first reported a position in LMAT in Q3 2022 and held it in 3 quarters. The position peaked at $726K in Q1 2024. 261 funds tracked by Wall St. Rank hold LMAT as of Q2 2024.

  • Park Avenue Securities reported no remaining LeMaitre Vascular position as of Q2 2024 after selling out during the quarter.
  • Park Avenue Securities sold 10,947 LeMaitre Vascular shares in Q2 2024, an estimated $726K.
  • Park Avenue Securities first reported a position in LeMaitre Vascular in Q3 2022 and held it in 3 quarters.
  • Park Avenue Securities's LeMaitre Vascular position peaked at $726K in Q1 2024.
  • 261 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2024.

Based on Park Avenue Securities's 13F filing for Q2 2024, filed 9 Jul 2024.